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The Task Force on Malaria Research Capability
Strengthening (RCS) in Africa, coordinated by the United
Nations Development Programme, the World Bank, and the
World Health Organization (WHO) Special Programme for
Research and Training in Tropical Diseases (TDR),
represents a collaborative funding strategy in which multiple
agencies and governments promote capacity-building activi-
ties in the context of the Multilateral Initiative for Malaria in
Africa (MIM). This task force was established to promote
human resource development and strengthen research
capacity in malaria-endemic countries.
A total of 112 proposals involving 42 countries (25 from
Africa) and over 200 partner institutions/research groups
have been reviewed since the program’s inception in 1998.
The proposals covered a wide range of aspects of malaria
research, including the clinical and molecular basis of drug
resistance, drug policy, immune responses to Plasmodium
infection, evaluation of natural products for antimalarial
activity, parasite diversity, home management, vector
biology, and epidemiology of malaria. The task force has
recommended for funding, 23 full proposals involving 24
African and 8 European countries and the USA, with annual
budgets ranging from US $60,000 to US $250,000. Twenty
Ph.D. and 17 M.Sc. training grants were also approved in
connection with the funded projects. In addition, support was
also recommended for a few proposals that would promote
interactions between partners for improving protocols and
collecting preliminary data.
 Task Force Objectives
The objective of the malaria RCS grants is to develop or
strengthen, core African research groups’ (engaged in basic
or applied science) capacity for producing effective control
tools for malaria and improving relevant health policy
strategies. The task force believes there is an urgent need
to attract scientists with new skills to foster genuine
partnerships based on national and regional priorities,
mutual and complementary scientific objectives, expertise,
and shared responsibility. The partnerships will also
provide opportunities to study specific aspects of malaria at
multiple sites.
 Research Priorities
The task force encourages research projects or programs to
help establish networks focusing on the following areas, in-
cluding multidisciplinary cross-cutting innovative approaches.
Antimalarial drug policy and chemotherapy—develop
ment of strategies for rapid mapping of drug resistance;
innovative approaches for preventing, retarding, and
reversing drug resistance; definition of criteria for
replacing first-line drugs.
Epidemiology—the use of new technologies to identify
parasite diversity and its effect on immune responses;
development of methods to measure the impact of
interventions; and development of simple and rapid
epidemiologic methods for mapping malaria morbidity
and mortality.
Pathogenesis and immunology—studies on parasite-
vector-host factors involved in severe disease and
malaria in pregnancy, with the aim of developing and
promoting improved control and management strategies
and of evaluating potential vaccine candidates.
Entomology and vector studies—screening of natural
local products for insecticidal and repellent properties,
application of molecular tools for studies on vector
biology, feeding behavior, vector capacity, insecticide
resistance, and population genetics with the aim of
identifying and developing effective strategies for vector
control in settings of low and high transmission.
Health systems research, including social science—
improvement of the home management of malaria on the
basis of community knowledge, community practices, and
the development of new products.
Natural products and antimalarial drug development—
promotion of systematic identification and chemical and
biological screening with in vitro and in vivo systems
for isolating antimalarial compounds from natural
products used by the indigenous populations for
treatment of fevers.
Project Profile
Proposals should be submitted and coordinated by an
African national scientist working in a research group in
Africa, and should include at least two African research
partner institutions (one established and one emerging) and
at least one non-African partner, which could be an
international institution with a base in Africa. All proposals
must describe in detail a plan for strengthening research
capability. The grants are awarded on the basis of scientific
merit, relevance, and quality of partnerships that promote
capacity building and human resource development in Africa.
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Enhancing Factors
Activities of the task force have been enhanced by the use
of unique strategies for identifying and managing the
research projects. These include the following:
Strengthening research capability through sound re-
search projects.
Developing a select group of projects around the interface
of bench work/control operations.
Focusing the research agenda in priority areas.
Maximizing training opportunities.
Working for more rapid funding and implementation.
Encouraging research collaboration among developing
country scientists and among developing and developed
country scientists.
Promoting higher funding levels, including salary
supplementation, for principal investigators to enhance
long-term career commitment to research in Africa.
Task Force Progress
The activities of the MIM/TDR-RCS have produced the
following results:
1. Continental networks for malaria mortality/demograph-
ic surveillance have been enhanced, including mapping
the risk of malaria and determining the relationship(s)
between transmission intensity and control activities in
Africa. These networks have hubs in South Africa,
Mozambique, Burkina Faso, and Ghana with 31
collaborating sites in 15 countries in Africa.
2. A model for collaboration between research scientists,
malaria control personnel, and policy makers has been
developed (Nigeria).
3. The impact of environmental modification for agricultur-
al activities on malaria transmission and morbidity has
been evaluated (Benin and Ivory Coast)
4. Simple molecular assays have been developed for the
surveillance of drug-resistant malaria, and results have
been used to make evidence-based malaria control policy
decisions (Mali and Tanzania)
.
5. Information has been obtained on the contributions of
tumor necrosis factor and soluble receptors to the
pathogenesis of cerebral malaria and severe malarial
anemia (Ghana).
6. National capacity has been strengthened in African
countries for rational selection of insecticides used in
vector control (South Africa, Benin.)
7. Biodiversity prospecting (discovery and development of
biochemical and genetic resources from plants, animals,
and microorganisms to be used in biotechnology
applications) has begun for new antimalaria compounds
and insecticides (Kenya and Nigeria).
8. Five African research centers have been established to
develop strategies for rapid mapping and control of drug-
resistant malaria (Ghana, Nigeria, Malawi, Mali, and
Tanzania).
Other accomplishments of the MIM/TDR-RCS include
conducting the following group learning activities between
March 1988 and March 2000:
Workshop on Research Capacity Development in Africa,
March 1999.
Workshop on Markers of Antimalarial Drug Resistance:
Practical, Clinical, and Epidemiological Applications,
June 1999.
Laboratory Training on Molecular Markers of Antimalar
ial Drug Resistance, January-February 2000. Jointly
organized by the MIM/TDR–RCS, National Institutes of
Health (NIH), Malaria Research and Reference Reagent
Resource Center (MR4), and Malaria Research Training
Center, Bamako.
Workshop on Handling and Managing Biological
Materials, March 2000. Jointly organized by the MR4,
American Type Culture Collection, MIM/TDR-RCS, and
Centre Nationale de Lutte Contre le Paludisme, Burkina
Faso.
Mini-Symposium on Biological Resource Centers in
Africa: Creating New Research Opportunities in Malaria,
March 2000. Jointly organized by the MIM/TDR–RCS
and MR4.
The success of this initiative will be confirmed by the
existence of a sustainable malaria research community,
which is capable of implementing relevant public health
interventions and policies across Africa.  The MIM/TDR
program represents an innovative approach to accomplish
this goal.